The 10-second takeaway
For the quarter ended March 31 (Q1), Herbalife met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly. Non-GAAP earnings per share increased significantly. GAAP earnings per share expanded significantly.
Gross margins increased, operating margins contracted, net margins dropped.
Herbalife chalked up revenue of $1.12 billion. The five analysts polled by S&P Capital IQ hoped for net sales of $1.11 billion on the same basis. GAAP reported sales were 17% higher than the prior-year quarter's $964.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.27. The seven earnings estimates compiled by S&P Capital IQ predicted $1.06 per share. Non-GAAP EPS of $1.27 for Q1 were 44% higher than the prior-year quarter's $0.88 per share. GAAP EPS of $1.10 for Q1 were 25% higher than the prior-year quarter's $0.88 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 79.9%, much better than the prior-year quarter. Operating margin was 15.0%, 100 basis points worse than the prior-year quarter. Net margin was 10.6%, 60 basis points worse than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $1.17 billion. On the bottom line, the average EPS estimate is $1.27.
Next year's average estimate for revenue is $4.62 billion. The average EPS estimate is $4.66.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 456 members out of 666 rating the stock outperform, and 210 members rating it underperform. Among 180 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 104 give Herbalife a green thumbs-up, and 76 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Herbalife is outperform, with an average price target of $61.43.
Looking for alternatives to Herbalife? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add Herbalife to My Watchlist.